Cynatratoside ACAS# 97399-96-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 97399-96-7 | SDF | Download SDF |
| PubChem ID | 175701 | Appearance | Powder |
| Formula | C28H40O8 | M.Wt | 504.62 |
| Type of Compound | Steroids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 8-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.04,13.05,10.019,22]docosa-1(21),10-dien-14-one | ||
| SMILES | CC1C(C(CC(O1)OC2CCC3(C4CCC5=COC6(C5C(CO6)OC(=O)C4CC=C3C2)C)C)OC)O | ||
| Standard InChIKey | QANVGLGBLJFUIP-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C28H40O8/c1-15-25(29)21(31-4)12-23(34-15)35-18-9-10-27(2)17(11-18)6-7-19-20(27)8-5-16-13-32-28(3)24(16)22(14-33-28)36-26(19)30/h6,13,15,18-25,29H,5,7-12,14H2,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Cynatratoside A and Cynanversicoside C are therefore potential candidate drugs for use against Ichthyophthirius multifiliis. |
| Targets | Antifection |
Cynatratoside A Dilution Calculator
Cynatratoside A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9817 mL | 9.9084 mL | 19.8169 mL | 39.6338 mL | 49.5422 mL |
| 5 mM | 0.3963 mL | 1.9817 mL | 3.9634 mL | 7.9268 mL | 9.9084 mL |
| 10 mM | 0.1982 mL | 0.9908 mL | 1.9817 mL | 3.9634 mL | 4.9542 mL |
| 50 mM | 0.0396 mL | 0.1982 mL | 0.3963 mL | 0.7927 mL | 0.9908 mL |
| 100 mM | 0.0198 mL | 0.0991 mL | 0.1982 mL | 0.3963 mL | 0.4954 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Paniculidine C
Catalog No.:BCN4524
CAS No.:97399-95-6
- Paniculidine B
Catalog No.:BCN4523
CAS No.:97399-94-5
- Paniculidine A
Catalog No.:BCN4522
CAS No.:97399-93-4
- Aristolactam AIIIa
Catalog No.:BCN4521
CAS No.:97399-91-2
- Aristolactam AIa
Catalog No.:BCN4854
CAS No.:97399-90-1
- 3alpha-Hydroxytanshinone IIA
Catalog No.:BCN2496
CAS No.:97399-71-8
- 8-Hydroxy-4-cadinen-3-one
Catalog No.:BCN4520
CAS No.:97372-53-7
- Troglitazone
Catalog No.:BCC2016
CAS No.:97322-87-7
- Topiramate
Catalog No.:BCC2314
CAS No.:97240-79-4
- Picfeltarraenin IA
Catalog No.:BCN1041
CAS No.:97230-47-2
- Picfeltarraenin IB
Catalog No.:BCN2845
CAS No.:97230-46-1
- Eriobofuran
Catalog No.:BCN7436
CAS No.:97218-06-9
- Tanshindiol A
Catalog No.:BCN3123
CAS No.:97411-46-6
- 2',3'-Dehydrosalannol
Catalog No.:BCN4549
CAS No.:97411-50-2
- (-)-Mandelic acid benzyl ester
Catalog No.:BCC8374
CAS No.:97415-09-3
- (-)-5'-DMH-CBD
Catalog No.:BCC5769
CAS No.:97452-63-6
- Cycloart-22-ene-3,25-diol
Catalog No.:BCN4525
CAS No.:97456-49-0
- Tanshindiol B
Catalog No.:BCN3124
CAS No.:97465-70-8
- Tanshindiol C
Catalog No.:BCN3125
CAS No.:97465-71-9
- α-Methyl-5-hydroxytryptamine maleate
Catalog No.:BCC6696
CAS No.:97469-12-0
- Pericyclivine
Catalog No.:BCN3974
CAS No.:975-77-9
- Ceftibuten
Catalog No.:BCC5216
CAS No.:97519-39-6
- 3-O-Caffeoyloleanolic acid
Catalog No.:BCN3959
CAS No.:97534-10-6
- Quinelorane hydrochloride
Catalog No.:BCC7100
CAS No.:97548-97-5
Seco-pregnane steroids target the subgenomic RNA of alphavirus-like RNA viruses.[Pubmed:17470783]
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8083-8.
Plants have evolved multiple mechanisms to selectively suppress pathogens by production of secondary metabolites with antimicrobial activities. Therefore, direct selections for antiviral compounds from plants can be used to identify new agents with potent antiviral activity but not toxic to hosts. Here, we provide evidence that a class of compounds, seco-pregnane steroid glaucogenin C and its monosugar-glycoside Cynatratoside A of Strobilanthes cusia and three new pantasugar-glycosides of glaucogenin C of Cynanchum paniculatum, are effective and selective inhibitors to alphavirus-like positive-strand RNA viruses including plant-infecting tobacco mosaic virus (TMV) and animal-infecting Sindbis virus (SINV), eastern equine encephalitis virus, and Getah virus, but not to other RNA or DNA viruses, yet they were not toxic to host cells. In vivo administration of the compounds protected BALB/c mice from lethal SINV infection without adverse effects on the mice. Using TMV and SINV as models, studies on the action mechanism revealed that the compounds predominantly suppress the expression of viral subgenomic RNA(s) without affecting the accumulation of viral genomic RNA. Our work suggested that the viral subgenomic RNA could be a new target for the discovery of antiviral drugs, and that seco-pregnane steroid and its four glycosides found in the two medicinal herbs have the potential for further development as antiviral agents against alphavirus-like positive-strand RNA viruses.
Steroidal glycosides from Cynanchum forrestii Schlechter.[Pubmed:16256157]
Steroids. 2006 Jan;71(1):67-76.
Nine new steroidal glycosides, cynaforrosides B, C, D, E, and F, based on a 13, 14: 14, 15-disecopregnane-type skeleton, cynaforrosides G, H, and I with a new aglycone named cynaforrogenin A, and cynaforroside J together with three known C21 steroidal glycosides Cynatratoside A, hancoside and komaroside C were isolated from the ethanol extract of the roots of Cynanchum forrestii Schlechter. The structures of new compounds were determined on the basis of spectral and chemical evidence. Steroidal glycosides with three kinds of skeletons were isolated from this plant simultaneously. The sugar units of cynaforrosides B-I contained two moieties of glucoses and especially cynaforrosides E-I contained two glucoses with the mode of 1-->6 linkage, which were rare among steroidal glycosides of the genus Cynanchum.
[C21 steroidal constituents from Cynanchum hancockianum].[Pubmed:1481676]
Yao Xue Xue Bao. 1992;27(8):595-602.
Two new compounds hancogenin B (V) and hancoside A (VI) and four known compounds glucogenin C (I), Cynatratoside A (II), glaucogenin A (III) and anhydrohirundigenin (IV) were isolated from the roots of Cynanchum hancockianum (Maxim) Al. Iljinski. Their structures were identified on the basis of spectral evidence. The fragmentation ways of 13:14, 14:15-secopregnenes in EIMS were outlined and the antitumor activity of II and the antiendotoxic activity of VI were also preliminarily tested in vitro.
Two new 13,14:14,15-disecopregnane-type compounds from the roots of Cynanchum paniculatum.[Pubmed:26465069]
J Asian Nat Prod Res. 2016;18(4):339-43.
Two new 13,14:14,15-disecopregnane-type compounds glaucogenin F (1), glaucogenin F 3-O-beta-D-oleandropyranoside (2), together with three known compounds cynapanoside A (3), Cynatratoside A (4), and neocynapanogenin F 3-O-beta-D-oleandropyranoside (5) were isolated from the 95% ethanol extract of the roots of Cynanchum paniculatum. The structures of new compounds were elucidated on the basis of extensive spectroscopic analyses, including 1D and 2D NMR, HRESIMS and NOESY.
Steroidal glycosides from the roots of Cynanchum amplexicaule Sieb. et Zucc.[Pubmed:18343471]
Steroids. 2008 Jul;73(6):629-36.
Seven new steroidal glycosides (amplexicosides A (4), B (7), C (8), D (9), E (10), F (11), and G (12)), along with six known compounds (Cynatratoside A (1), tylophoside A (2), cynatratoside B (3), glaucogenin A (5), glaucoside A (6), and hancoside A (13)) were isolated from the 95% ethanol extract of the roots of Cynanchum amplexicaule (Sieb. et Zucc.). Their structures were determined based on spectral and chemical evidence. Compound 12 has a 14, 15-secopregnane-type skeleton aglycone, which has not been reported in literature.
